• H
  • L
  • S
    Stability & Bio Storage
  • C

Proposed acquisition of Select Pharma Laboratories Ltd

The Board of Source BioScience is delighted to announce that it has conditionally agreed to acquire the entire issued share capital of Select Pharma Laboratories Ltd (‘Select’) for a total cash consideration of up to £7.3 million.

C. elegans: what's all the fuss?

Already working on C. elegans? Enhance your research with our extensive collection of C. elegans clones and clone libraries. Search now in GenomeCUBE®

Annual General Meeting Statement

Laurie Turnbull, Chairman of Source BioScience, will be making the following comments at the 2015 Annual General Meeting to be held today at 10.30am:

Notice of Annual General Meeting

Source BioScience (LSE: SBS) announces that the 2015 Annual General Meeting will be held at the Company's Registered Office, 1 Orchard Place, Nottingham Business Park, Nottingham NG8 6PX at 10.30 am on 11 June 2015. Formal notice of this meeting is available on the website and has been posted to shareholders together with a copy of the 2014 Annual Report and Accounts, a copy of which can be downloaded from the Source BioScience website -

Total Voting Rights

In accordance with the FCA's Disclosure and Transparency Rules, Source BioScience plc confirms that as at 30 April 2015 the Company has 313,837,652 ordinary shares of 2 pence each in issue.

Additional Listing on Exercise of Share Options

Source BioScience plc announces that it has issued 263,687 new ordinary shares of 2 pence each in the Company following the exercise of options under the Company's 1999 Unapproved and 2001 Approved Share Option schemes.

Holdings in Company

The attached TR1 notification relates to the shareholding in Source BioScience plc held by Henderson Global Investors which now stands at 60,142,788 shares, representing 19.18% of the Company’s ordinary share capital.